/PRNewswire/ March 27, 2024, CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the.
EQS-News: Heidelberg Pharma AG / Key word: Annual Results
Heidelberg Pharma announces financial figures and reports on successful business performance in 2023
25.03.2024.
First efficacy data from the clinical trial with HDP-101 in multiple myelomaExpansion of the ADC technology platform to include further payloadsNew Management Board teamSuccessful financing activities; sales revenue and other income above planConference call to be held on 25 March 2024 at 03:00 pm CET/ 10:00 am EDT&.